Triazolones, tetrazolones, and imidazolones, or their salts, and pharmaceutical compositions comprising the same
US12110279B2 · kind B2 · utility
0Cited by
7References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 21, 2022 |
| Grant date | Oct 8, 2024 |
| Priority date | — |
| Expiry date | Apr 21, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D401/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present technology provides triazolones, tetrazolones, and imidazolones, or pharmaceutically acceptable salts thereof, preparation processes thereof, pharmaceutical compositions comprising the same, and uses thereof. The triazolones, tetrazolones, and imidazolones or their pharmaceutically acceptable salts exhibit inhibitory activity on VAP-1 and therefore can be usefully applied, e.g., for the treatment and prophylaxis of nonalcoholic hepatosteatosis (NASH).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.